ATLANTA (Reuters) – Adding a drug that lowers blood fats known as triglycerides to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study. [...]
ATLANTA (Reuters) – Adding a triglyceride lowering drug to cholesterol fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study. [...]
NEW YORK (Reuters) – Merck & Co on Thursday said an independent data safety monitoring board has approved continuation of a big study meant to determine whether its blockbuster Vytorin cholesterol drug prevents heart attacks and stroke. [...]
LONDON (Reuters) – Only half of patients at high risk of heart disease are given the right targets for cutting their cholesterol and millions may suffer heart attack or stroke due to doctors’ poor advice, scientists said on Thursday. [...]
NEW YORK (Reuters Health) – People who have had an attack of shingles involving the eyes may have a heightened risk of stroke for a year afterward, a study published Wednesday suggests. [...]
CHICAGO (Reuters) – Working with the food industry to cut salt intake by nearly 10 percent could prevent hundreds of thousands of heart attacks and strokes over several decades and save the U.S. government $32 billion in healthcare costs, U.S. researchers said on Monday. [...]
NEW YORK (Reuters Health) – Don’t expect your calcium and vitamin D supplements to improve your heart health or prevent a stroke, according to a systematic review of published studies. [...]
CHICAGO (Reuters) – A newer, less invasive approach to preventing strokes using a device called a stent proved to be as safe and worked just about as well as surgery, U.S. researchers said on Friday, a finding that may be a boon to medical device makers. [...]
NEW YORK (Reuters Health) – A woman’s risk of heart disease and stroke in middle-age and beyond may be associated with the number of children she gives birth to, a large study of Swedish women hints. [...]
COPENHAGEN (Reuters) – Danish pharmaceutical group Lundbeck said on Thursday a new analysis of a clinical phase III trial with its candidate stroke drug Desmoteplase showed positive results. [...]